230 related articles for article (PubMed ID: 31620737)
21. A triple modality BSA-coated dendritic nanoplatform for NIR imaging, enhanced tumor penetration and anticancer therapy.
Cao J; Ge R; Zhang M; Xia J; Han S; Lu W; Liang Y; Zhang T; Sun Y
Nanoscale; 2018 May; 10(19):9021-9037. PubMed ID: 29717725
[TBL] [Abstract][Full Text] [Related]
22. Azo-based small molecular hypoxia responsive theranostic for tumor-specific imaging and therapy.
Zhou Y; Maiti M; Sharma A; Won M; Yu L; Miao LX; Shin J; Podder A; Bobba KN; Han J; Bhuniya S; Kim JS
J Control Release; 2018 Oct; 288():14-22. PubMed ID: 30170068
[TBL] [Abstract][Full Text] [Related]
23. Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release.
Ferber S; Baabur-Cohen H; Blau R; Epshtein Y; Kisin-Finfer E; Redy O; Shabat D; Satchi-Fainaro R
Cancer Lett; 2014 Sep; 352(1):81-9. PubMed ID: 24614283
[TBL] [Abstract][Full Text] [Related]
24. A fluorescence-activatable tumor-reporting probe for precise photodynamic therapy.
Li J; Wang T; Jiang F; Hong Z; Su X; Li S; Han S
J Mater Chem B; 2021 Jul; 9(29):5829-5836. PubMed ID: 34254096
[TBL] [Abstract][Full Text] [Related]
25. In vivo near-infrared imaging and phototherapy of tumors using a cathepsin B-activated fluorescent probe.
Chen X; Lee D; Yu S; Kim G; Lee S; Cho Y; Jeong H; Nam KT; Yoon J
Biomaterials; 2017 Apr; 122():130-140. PubMed ID: 28113107
[TBL] [Abstract][Full Text] [Related]
26. Amphiphilic redox-sensitive NIR BODIPY nanoparticles for dual-mode imaging and photothermal therapy.
Wang X; Lin W; Zhang W; Li C; Sun T; Chen G; Xie Z
J Colloid Interface Sci; 2019 Feb; 536():208-214. PubMed ID: 30368092
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-Activated and Indomethacin-Mediated Theranostic Prodrug Releasing Drug On-Demand for Tumor Imaging and Therapy.
Peng X; Gao J; Yuan Y; Liu H; Lei W; Li S; Zhang J; Wang S
Bioconjug Chem; 2019 Nov; 30(11):2828-2843. PubMed ID: 31592652
[TBL] [Abstract][Full Text] [Related]
28. Near-Infrared Fluorescent Probe Activated by Nitroreductase for
Karan S; Cho MY; Lee H; Lee H; Park HS; Sundararajan M; Sessler JL; Hong KS
J Med Chem; 2021 Mar; 64(6):2971-2981. PubMed ID: 33711229
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-sensitive fluorescent probes for in vivo real-time fluorescence imaging of acute ischemia.
Kiyose K; Hanaoka K; Oushiki D; Nakamura T; Kajimura M; Suematsu M; Nishimatsu H; Yamane T; Terai T; Hirata Y; Nagano T
J Am Chem Soc; 2010 Nov; 132(45):15846-8. PubMed ID: 20979363
[TBL] [Abstract][Full Text] [Related]
30. In vivo tumor imaging by a γ-glutamyl transpeptidase-activatable near-infrared fluorescent probe.
Li L; Shi W; Wu X; Li X; Ma H
Anal Bioanal Chem; 2018 Oct; 410(26):6771-6777. PubMed ID: 29909457
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of sulfane sulfur bioeffects via a mitochondria-targeting selenium-containing near-infrared fluorescent probe.
Gao M; Wang R; Yu F; Chen L
Biomaterials; 2018 Apr; 160():1-14. PubMed ID: 29348054
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-directed and activated theranostic agent: Imaging and treatment of solid tumor.
Kumar R; Kim EJ; Han J; Lee H; Shin WS; Kim HM; Bhuniya S; Kim JS; Hong KS
Biomaterials; 2016 Oct; 104():119-28. PubMed ID: 27449948
[TBL] [Abstract][Full Text] [Related]
33. Near-Infrared Fluorescent Probe with Remarkable Large Stokes Shift and Favorable Water Solubility for Real-Time Tracking Leucine Aminopeptidase in Living Cells and In Vivo.
Zhang W; Liu F; Zhang C; Luo JG; Luo J; Yu W; Kong L
Anal Chem; 2017 Nov; 89(22):12319-12326. PubMed ID: 29048879
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence-Guided Cancer Diagnosis and Surgery by a Zero Cross-Talk Ratiometric Near-Infrared γ-Glutamyltranspeptidase Fluorescent Probe.
Ou-Yang J; Li Y; Jiang WL; He SY; Liu HW; Li CY
Anal Chem; 2019 Jan; 91(1):1056-1063. PubMed ID: 30539637
[TBL] [Abstract][Full Text] [Related]
35. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
[TBL] [Abstract][Full Text] [Related]
36. Real-time monitoring of γ-Glutamyltranspeptidase in living cells and in vivo by near-infrared fluorescent probe with large Stokes shift.
Liu F; Wang Z; Zhu T; Wang W; Nie B; Li J; Zhang Y; Luo J; Kong L
Talanta; 2019 Jan; 191():126-132. PubMed ID: 30262041
[TBL] [Abstract][Full Text] [Related]
37. Theranostic niosomes for direct intratumoral injection: marked enhancement in tumor retention and anticancer efficacy.
Nowroozi F; Dadashzadeh S; Soleimanjahi H; Haeri A; Shahhosseini S; Javidi J; Karimi H
Nanomedicine (Lond); 2018 Sep; 13(17):2201-2219. PubMed ID: 29993311
[TBL] [Abstract][Full Text] [Related]
38. Near infrared active heptacyanine dyes with unique cancer-imaging and cytotoxic properties.
Henary M; Pannu V; Owens EA; Aneja R
Bioorg Med Chem Lett; 2012 Jan; 22(2):1242-6. PubMed ID: 22177785
[TBL] [Abstract][Full Text] [Related]
39. Flavylium-Based Hypoxia-Responsive Probe for Cancer Cell Imaging.
Pewklang T; Wet-Osot S; Wangngae S; Ngivprom U; Chansaenpak K; Duangkamol C; Lai RY; Noisa P; Sukwattanasinitt M; Kamkaew A
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443527
[TBL] [Abstract][Full Text] [Related]
40. Direct Readout Hypoxia Tumor Suppression In Vivo through NIR-Theranostic Activation.
Zhao YQ; Biswas S; Chen Q; Jia M; Zhou Y; Bhuniya S
ACS Appl Bio Mater; 2021 Jul; 4(7):5686-5694. PubMed ID: 35006742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
